Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20184954rdf:typepubmed:Citationlld:pubmed
pubmed-article:20184954lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:20184954lifeskim:mentionsumls-concept:C0178602lld:lifeskim
pubmed-article:20184954lifeskim:mentionsumls-concept:C0032214lld:lifeskim
pubmed-article:20184954lifeskim:mentionsumls-concept:C0600138lld:lifeskim
pubmed-article:20184954lifeskim:mentionsumls-concept:C1332817lld:lifeskim
pubmed-article:20184954lifeskim:mentionsumls-concept:C1704964lld:lifeskim
pubmed-article:20184954lifeskim:mentionsumls-concept:C2003941lld:lifeskim
pubmed-article:20184954lifeskim:mentionsumls-concept:C0600210lld:lifeskim
pubmed-article:20184954lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:20184954pubmed:issue7lld:pubmed
pubmed-article:20184954pubmed:dateCreated2010-4-27lld:pubmed
pubmed-article:20184954pubmed:abstractTextHematopoietic-specific RhoGTPase RhoH displays an important role in regulating T-cell development, a process that is accompanied by ordered and directed migration of progenitors through thymus. While RhoGTPases are key regulators of cytokinesis, the precise role of RhoH in T-cell migration is unknown. Here, by using Jurkat cell migration as a model, we found that RhoH is required for cell migration in response to the high concentration of SDF1 alpha but displays inhibitory roles in regulating migration in the absence of SDF1 alpha or in the range of low concentrations. We further found that RhoH-mediated migration requires PAK1 but not ITK. Indeed, both the low and high concentrations of SDF1 alpha activate PAK1 but only the high concentration-induced activation of PAK1 requires RhoH. Further study of the RhoH-PAK interaction revealed that RhoH is able to bind and activate PAK1, indicating that RhoH plays a positive role in response to the high concentration of SDF1 alpha. In contrast, at rest, RhoH indirectly inhibits Slp76/ITK activity through its modulation on TCR signaling, supporting a negative regulatory role for RhoH when SDF1 alpha is insufficient to activate the RhoH-PAK1 pathway. Together, our study uncovered a dual role for RhoH in SDF1 alpha signaling in T-cell responses.lld:pubmed
pubmed-article:20184954pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20184954pubmed:languageenglld:pubmed
pubmed-article:20184954pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20184954pubmed:citationSubsetIMlld:pubmed
pubmed-article:20184954pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20184954pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20184954pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20184954pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20184954pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20184954pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20184954pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20184954pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20184954pubmed:statusMEDLINElld:pubmed
pubmed-article:20184954pubmed:monthJullld:pubmed
pubmed-article:20184954pubmed:issn1873-3913lld:pubmed
pubmed-article:20184954pubmed:authorpubmed-author:WangHongHlld:pubmed
pubmed-article:20184954pubmed:authorpubmed-author:LimBingBlld:pubmed
pubmed-article:20184954pubmed:authorpubmed-author:ZengXinXlld:pubmed
pubmed-article:20184954pubmed:authorpubmed-author:FanZhigangZlld:pubmed
pubmed-article:20184954pubmed:copyrightInfo(c) 2010. Published by Elsevier Inc.lld:pubmed
pubmed-article:20184954pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20184954pubmed:volume22lld:pubmed
pubmed-article:20184954pubmed:ownerNLMlld:pubmed
pubmed-article:20184954pubmed:authorsCompleteYlld:pubmed
pubmed-article:20184954pubmed:pagination1022-32lld:pubmed
pubmed-article:20184954pubmed:meshHeadingpubmed-meshheading:20184954...lld:pubmed
pubmed-article:20184954pubmed:meshHeadingpubmed-meshheading:20184954...lld:pubmed
pubmed-article:20184954pubmed:meshHeadingpubmed-meshheading:20184954...lld:pubmed
pubmed-article:20184954pubmed:meshHeadingpubmed-meshheading:20184954...lld:pubmed
pubmed-article:20184954pubmed:meshHeadingpubmed-meshheading:20184954...lld:pubmed
pubmed-article:20184954pubmed:meshHeadingpubmed-meshheading:20184954...lld:pubmed
pubmed-article:20184954pubmed:meshHeadingpubmed-meshheading:20184954...lld:pubmed
pubmed-article:20184954pubmed:meshHeadingpubmed-meshheading:20184954...lld:pubmed
pubmed-article:20184954pubmed:meshHeadingpubmed-meshheading:20184954...lld:pubmed
pubmed-article:20184954pubmed:year2010lld:pubmed
pubmed-article:20184954pubmed:articleTitleRhoH plays distinct roles in T-cell migrations induced by different doses of SDF1 alpha.lld:pubmed
pubmed-article:20184954pubmed:affiliationDivision of Hematology and Oncology, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Ave., Boston, MA 02215, USA. howang@rci.rutgers.edulld:pubmed
pubmed-article:20184954pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20184954pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:20184954pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed